T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Roper Technologies
ROP
|
$795M |
| 2 |
Abbott
ABT
|
$750M |
| 3 |
Thermo Fisher Scientific
TMO
|
$746M |
| 4 |
Becton Dickinson
BDX
|
$730M |
| 5 |
Cigna
CI
|
$725M |
Top Sells
| 1 |
Salesforce
CRM
|
$1.32B |
| 2 |
Martin Marietta Materials
MLM
|
$959M |
| 3 |
Linde
LIN
|
$839M |
| 4 |
AbbVie
ABBV
|
$829M |
| 5 |
Intercontinental Exchange
ICE
|
$814M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 20.82% |
| 3 | Consumer Discretionary | 12.47% |
| 4 | Industrials | 10.66% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Carlisle Companies
CSL
$16.9B
| $308K | ﹤0.01% |
835
-52
| -6% | -$19.2K |
|
627
Steris
STE
$24.2B
| $291K | ﹤0.01% |
+1,415
| New | +$291K |
|
628
Accenture
ACN
$159B
| $288K | ﹤0.01% |
817
-16,577
| -95% | -$5.84M |
|
629
A.O. Smith
AOS
$10.3B
| $285K | ﹤0.01% |
4,173
-1,344
| -24% | -$91.8K |
|
630
Snap-on
SNA
$17.1B
| $273K | ﹤0.01% |
803
+10
| +1% | +$3.4K |
|
631
Parker-Hannifin
PH
$96.1B
| $236K | ﹤0.01% |
371
-240
| -39% | -$153K |
|
632
Etsy
ETSY
$5.36B
| $82K | ﹤0.01% |
1,535
-63,988
| -98% | -$3.42M |
|
|
ADVWW
633
Advantage Solutions Warrant
ADVWW
| $7K | ﹤0.01% |
545,310
-30,137
| -5% | -$387 |
|
634
BorgWarner
BWA
$9.53B
| – | – |
-604,562
| Closed | -$21.9M |
|
635
Caleres
CAL
$531M
| – | – |
-2,171,459
| Closed | -$71.8M |
|
636
Cadence Design Systems
CDNS
$95.6B
| – | – |
-10,034
| Closed | -$2.72M |
|
637
Cadre Holdings
CDRE
$1.3B
| – | – |
-888,033
| Closed | -$33.7M |
|
638
CrowdStrike
CRWD
$105B
| – | – |
-405,308
| Closed | -$114M |
|
639
DoubleVerify
DV
$2.45B
| – | – |
-6,234,929
| Closed | -$105M |
|
640
e.l.f. Beauty
ELF
$7.6B
| – | – |
-66,817
| Closed | -$7.29M |
|
641
Elastic
ESTC
$9.21B
| – | – |
-267,751
| Closed | -$20.6M |
|
642
Entergy
ETR
$39.2B
| – | – |
-8,362
| Closed | -$551K |
|
643
Diamondback Energy
FANG
$40.2B
| – | – |
-90,179
| Closed | -$15.5M |
|
644
GoodRx Holdings
GDRX
$1.39B
| – | – |
-3,814,170
| Closed | -$26.5M |
|
645
Structure Therapeutics
GPCR
$1.27B
| – | – |
-715,968
| Closed | -$31.4M |
|
646
Goldman Sachs
GS
$223B
| – | – |
-6,063
| Closed | -$3M |
|
647
Healthcare Realty
HR
$6.35B
| – | – |
-3,451,464
| Closed | -$62.6M |
|
648
Hawkins
HWKN
$3.49B
| – | – |
-50,020
| Closed | -$6.38M |
|
649
Janus International
JBI
$1.44B
| – | – |
-1,703,905
| Closed | -$17.2M |
|
650
Lifestance Health
LFST
$2.09B
| – | – |
-4,481,379
| Closed | -$31.4M |
|